Notice: This company has been marked as potentially delisted and may not be actively trading. Odonate Therapeutics (ODT) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Odonate Inc ODTCJuly 28, 2024 | morningstar.comProQR Therapeutics NV (PRQR)February 6, 2024 | investing.comOrally Disintegrating Tablet (ODT) Market 2023 | Future Exploration by 2030March 29, 2023 | marketwatch.comPfizer recalls migraine drug Nurtec ODT after millions of products lacked child resistant packagingMarch 19, 2023 | usatoday.comFate Therapeutics Stock (NASDAQ:FATE), Analyst Ratings, Price Targets, PredictionsMarch 3, 2023 | benzinga.comOrally Disintegrating Tablet (ODT) Market Size 2023 with Big Company Segment, Cost-Effective Solutions Analysis Information 2029January 31, 2023 | marketwatch.comODTC Odonate Therapeutics, Inc.October 22, 2022 | seekingalpha.comOdonate TherapeuticsSeptember 14, 2022 | forbes.comODONATE INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Odonate Therapeutics, Inc. - ODTDecember 10, 2021 | finance.yahoo.comOdonate Therapeutics Insider Sold Over $2.5M In Company StockNovember 22, 2021 | finance.yahoo.comOdonate Therapeutics, Inc. (ODT)October 27, 2021 | uk.finance.yahoo.comOne Odonate Therapeutics, Inc. (NASDAQ:ODT) insider upped their stake in the previous yearSeptember 27, 2021 | nasdaq.comSHAREHOLDER ALERT: Morris Kandinov Investigating ODT, AYTU, EAR, and CORT; Shareholders are Encouraged to Contact the FirmSeptember 8, 2021 | finance.yahoo.comA Odonate Therapeutics, Inc. (NASDAQ:ODT) insider increased their holdings last yearSeptember 6, 2021 | finance.yahoo.comOdonate Therapeutics Inc.August 26, 2021 | barrons.comODONATE INVESTIGATION INITIATED by Former...August 21, 2021 | benzinga.comUpdate in Lawsuit for Investors in Odonate Therapeutics, Inc. (NASDAQ:ODT) Announced by Shareholders FoundationAugust 17, 2021 | finance.yahoo.comKaskela Law LLC Announces Stockholder Investigation of Odonate Therapeutics, Inc. - ODTAugust 16, 2021 | finance.yahoo.comSHAREHOLDER ALERT: Odonate Therapeutics, Inc. (ODT) Officers and Directors Under Investigation for Possible False Statements to InvestorsAugust 13, 2021 | finance.yahoo.comNASDAQ: ODT Investor Notice: Update in Lawsuit against Odonate Therapeutics, Inc. announced by Shareholders FoundationAugust 10, 2021 | benzinga.comThe Law Offices of Frank R. Cruz Announces Investigation of Odonate Therapeutics, Inc. (ODT) on Behalf of InvestorsAugust 7, 2021 | finance.yahoo.comOdonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021July 27, 2021 | finance.yahoo.com Get Odonate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ODT and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher. This could be his favorite coin. ODT Media Mentions By Week ODT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ODT News Sentiment▼0.000.49▲Average Medical News Sentiment ODT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ODT Articles This Week▼00▲ODT Articles Average Week Get Odonate Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ODT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Clever Leaves News Grifols News LAVA Therapeutics News Mainz Biomed News Pharvaris News Procaps Group News Atreca News XBiotech News Ardelyx News Mirum Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ODT) was last updated on 11/22/2024 by MarketBeat.com Staff From Our PartnersBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredA “Thank You Gift” From Pres. Trump - GeniusThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump Returns...Inflation Fears SkyrocketTrump's back in the White House, but here's what they're not telling you: his plans could cause inflation to s...Oasis Gold | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredThe #1 Bitcoin ETF For Monthly DividendsYou don't have to own any Bitcoin to collect BIG dividends from it... Now, thanks to this brand new Bitcoin...Investors Alley | Sponsored“Trump Trades” You’ve Got to MakeThese Stocks are the Best “Trump Trades” Free e-book reveals sectors – and stocks within them – likely to p...StockEarnings | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Odonate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Odonate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
